#diseaseprogression — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #diseaseprogression, aggregated by home.social.
-
https://www.europesays.com/ch/104840/ Can Novartis’ Fabhalta Strengthen Its Nephrology Franchise? #AlternativeComplementPathway #DiseaseProgression #Fabhalta #FDA #KidneyDamage #KidneyFunction #Novartis #proteinuria #TravereTherapeutics #VertexPharmaceuticals #ZacksInvestmentResearch
-
https://www.europesays.com/ch/104614/ FDA grants traditional approval to Novartis’ Fabhalta for IgAN #AlternativeComplementPathway #DiseaseProgression #FoodAndDrugAdministration #IgAN #KidneyFunction #KidneyHealth #Novartis
-
How to protect your roses from black spot disease https://www.allforgardening.com/1876034/how-to-protect-your-roses-from-black-spot-disease/ #BlackSpot #BlackSpotDisease #BlackSpots #DiseaseProgression #garden #gardening #PestInfestations
-
How to protect your roses from black spot disease https://www.allforgardening.com/1876034/how-to-protect-your-roses-from-black-spot-disease/ #BlackSpot #BlackSpotDisease #BlackSpots #DiseaseProgression #garden #gardening #PestInfestations
-
DATE: July 11, 2026 at 10:06PM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Yale scientists may have found how Parkinson's disease spreads through the brain
URL: https://www.sciencedaily.com/releases/2026/07/260710003529.htm
Yale scientists discovered two neuron surface proteins that appear to help spread the toxic protein linked to Parkinson’s disease. Blocking these proteins in mice dramatically reduced disease progression, offering a potential new target for future therapies.
URL: https://www.sciencedaily.com/releases/2026/07/260710003529.htm
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #ParkinsonsDisease #ParkinsonsResearch #Neurology #Neuroscience #YaleMedicine #NeuronProteins #DiseaseProgression #Neurodegeneration #Biomarkers #TherapeuticTargets
-
DATE: July 11, 2026 at 10:06PM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Yale scientists may have found how Parkinson's disease spreads through the brain
URL: https://www.sciencedaily.com/releases/2026/07/260710003529.htm
Yale scientists discovered two neuron surface proteins that appear to help spread the toxic protein linked to Parkinson’s disease. Blocking these proteins in mice dramatically reduced disease progression, offering a potential new target for future therapies.
URL: https://www.sciencedaily.com/releases/2026/07/260710003529.htm
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #ParkinsonsDisease #ParkinsonsResearch #Neurology #Neuroscience #YaleMedicine #NeuronProteins #DiseaseProgression #Neurodegeneration #Biomarkers #TherapeuticTargets
-
Press Release: Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study
Sanofi Winthrop Industrie Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study…
#France #FR #Europe #EU #Sanofi #cardiacmuscles #diseaseprogression #musclecells #Nexviazyme #participants #phase3study #Pompedisease
https://www.europesays.com/france/46130/ -
Press Release: Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study
Sanofi Winthrop Industrie Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study…
#France #FR #Europe #EU #Sanofi #cardiacmuscles #diseaseprogression #musclecells #Nexviazyme #participants #phase3study #Pompedisease
https://www.europesays.com/france/43634/ -
AstraZeneca Sees Encouraging Survival Trend In Liver Cancer Trial
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. AstraZeneca…
#EuropeSays #Britain #Europe #EU #AstraZeneca #AstraZenecaPLC #diseaseprogression #interimanalysis #lenvatinib #MemorialSloanKetteringCancerCenter #Patients #progression-freesurvival #STRIDE #TACE #theSTRIDE
https://www.europesays.com/britain/55569/ -
https://www.europesays.com/britain/55569/ AstraZeneca Sees Encouraging Survival Trend In Liver Cancer Trial #AstraZeneca #AstraZenecaPLC #DiseaseProgression #InterimAnalysis #lenvatinib #MemorialSloanKetteringCancerCenter #Patients #ProgressionFreeSurvival #STRIDE #TACE #TheSTRIDE
-
https://www.europesays.com/britain/48186/ AstraZeneca, Daiichi Sankyo’s Datroway receives FDA approval for TNBC #AstraZeneca #BreAstCancer #DaiichiSankyo #Datroway #DiseaseProgression #FoodAndDrugAdministration #MetastaticDisease #ProgrammedCellDeath #TNBC
-
https://www.europesays.com/ch/43565/ Novartis AG (NVS) Announces Final Two-Year Results From Phase III APPLAUSE‑IgAN Study #DiseaseProgression #IgAN #KidneyFailure #KidneyFunction #Novartis #NovartisAG
-
https://www.europesays.com/ch/?p=43197 Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3% #DiseaseProgression #IgANephropathy #KidneyDamage #KidneyFailure #KidneyFunction #Novartis
-
https://www.europesays.com/ch/40771/ Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3% #DiseaseProgression #IgANephropathy #KidneyDamage #KidneyFailure #KidneyFunction #Novartis